The activation of the Wnt/beta-catenin signaling pathway downregulates CCL5 expression and inhibits the DC recruitment process, resulting in increased resistance to ICIs and immune response escape in HCC patients (Ruiz de Galarreta et al., 2019). Here, CCL5 is linked to hepatocellular carcinoma.